FDA Drug recall D-0182-2026
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 633…
- FDA Drug
- Class I
- ongoing
- Published 2025-12-03
On 2025-12-03 the FDA classified a Class I recall of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 633… by Fresenius Kabi Usa, citing microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0182-2026 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2025-11-06 |
| Published | 2025-12-03 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Fresenius Kabi Usa |
| Distribution | US |
Product
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).
Reason
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Identifiers
| ndc | 63323-739-11 |
|---|---|
| ndc | 63323-739-12 |
| code_info | Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0182-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.